82 studies found for:    "Bacterial meningitis"
Show Display Options
Rank Status Study
1 Recruiting Slow Initial β-lactam Infusion With High-dose Paracetamol to Improve the Outcomes of Childhood Bacterial Meningitis
Condition: Bacterial Meningitis
Interventions: Drug: Infusion with paracetamol;   Drug: Bolus without paracetamol
2 Completed Oral Glycerol and High-Dose Rectal Paracetamol to Improve the Prognosis of Childhood Bacterial Meningitis
Condition: Bacterial Meningitis
Interventions: Drug: Glycerol and paracetamol;   Drug: Paracetamol;   Drug: Placebo;   Drug: Paracetamol and glycerol;   Drug: Glycerol
3 Recruiting Bacterial Meningitis in Adults: Analysis of the Determinants of Mortality and Neurosensory Sequelae
Condition: Meningitis, Bacterial
Intervention:
4 Active, not recruiting Infant Severe Sepsis and Bacterial Meningitis in Malawi
Condition: Infant Bacterial Meningitis
Intervention: Drug: Ceftriaxone v penicillin and gentamicin
5 Recruiting Surveillance of Hospitalised Pneumonia and Bacterial Meningitis in Tône District, Togo, 2010-2013
Conditions: Pneumonia, Bacterial;   Pneumonia, Viral;   Meningitis, Bacterial
Intervention:
6 Completed
Has Results
Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 18 Years in Taiwan
Condition: Bacterial Meningitis
Intervention: Biological: Meningococcal ACWY conjugate vaccine
7 Completed Immunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 75 Years of Age in India
Condition: Bacterial Meningitis
Intervention: Biological: Meningococcal ACWY conjugate vaccine
8 Terminated IHPOTOTAM : Induced HyPOthermia TO Treat Adult Meningitis
Condition: Bacterial Meningitis
Interventions: Procedure: Mild induced hypothermia (32-34°C);   Procedure: local recommendations and guidelines
9 Active, not recruiting Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases in Neurological Disorders in DRC
Conditions: Neurological Disorders;   Cerebral Malaria;   Bacterial Meningitis;   Central Nervous System Tuberculosis;   Neurosyphilis;   Cryptococcal Meningitis
Interventions: Device: Immunochromatographic HAT tests (DSD);   Device: Card Agglutination Trypanosoma Test;   Device: TB POC Nucleic Acid Amplification Test (Molbio Diagnostics);   Device: TB 3-marker RDT (Tulip diagnostics);   Device: Cryptococcal Antigen Lateral Flow Assay (Immy)
10 Withdrawn Amikacin Penetration Into the Cerebrospinal Fluid
Conditions: Gram Negative Meningitis;   Post Traumatic Bacterial Meningitis
Intervention: Drug: Systemic and Intra-Thecal Amikacin Therapy
11 Completed Safety and Immunogencitiy Study of MenC-TT Vaccine (NeisVac-C) in Toddlers Previously Immunized With PCV7 (Prevenar®)
Conditions: Neisseria Meningitidis (Bacterial Meningitis);   Invasive Pneumococcal Disease (IPD)
Interventions: Biological: Group C Meningococcal Polysaccharide-Tetansu Toxoid Conjugate (MenC-TT) vaccine and 7-valent Pneumococcal CRM197-conjugate vaccine (PCV7);   Biological: 7-valent Pneumococcal CRM197-conjugate vaccine (PCV7);   Biological: Group C Meningococcal Polysaccharide-Tetansu Toxoid Conjugate (MenC-TT)
12 Suspended Daptomycin in Pediatric Patients With Bacterial Meningitis
Conditions: Meningitis;   Gram-Positive Bacteria
Intervention: Drug: Daptomycin
13 Completed
Has Results
Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM
Conditions: Meningococcal Disease;   Meningococcal Meningitis;   Hepatitis A;   Hepatitis B
Interventions: Biological: MenACWY-CRM;   Biological: Combined inactivated hepatitis A and recombinant hepatitis B vaccine;   Biological: Recombinant hepatitis B vaccine;   Biological: Inactivated hepatitis A vaccine
14 Completed Safety Study of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine for Meningitis
Conditions: Meningococcal Meningitis;   Meningococcal Infections
Intervention: Biological: meningococcal meningitis conjugate vaccine, quadrivalent
15 Completed Study To Describe The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine In Laboratory Workers ≥18 To ≤65 Years Of Age
Condition: Meningitis, Meningococcal, Serogroup B
Intervention: Biological: rLP2086
16 Completed Safety and Immunogenicity of Chiron Meningococcal ACWY Conjugate Vaccine in Healthy Children Aged 12-59 Months.
Condition: Meningococcal Meningitis
Intervention: Biological: Men ACWY conjugate vaccine
17 Completed Immunogenicity & Safety Study of a Meningococcal Serogroup B Vaccine Given in a 3 Dose Schedule to Healthy Adolescents Aged 12-18 Yrs
Condition: Meningitis, Meningococcal, Serogroup B
Intervention: Biological: Meningococcal serogroup B vaccine
18 Completed
Has Results
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
Condition: Meningococcal Meningitis
Intervention: Biological: Meningococcal (groups A, C, W, and Y) oligosaccharide diphtheria CRM-197 conjugate vaccine
19 Completed Safety And Blood Collection Study Of Meningococcal B Rlp2086 Vaccine In Adults
Condition: Meningitis, Meningococcal
Interventions: Biological: meningococcal B rLP2086 vaccine candidate;   Procedure: Blood draw
20 Completed
Has Results
Safety and Immunogenicity of 2 or 3 Doses of MenACWY Conjugate Vaccine in Healthy Infants and the Effects of a Booster Dose of MenACWY Administered in the Second Year of Life
Conditions: Meningococcal Disease;   Meningococcal Meningitis
Interventions: Biological: MenACWY-CRM;   Biological: Routine Vaccines

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years